HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Constitutively active Akt contributes to vincristine resistance in human retinoblastoma cells.

Abstract
Akt mediates survival signals which preserve various cancer cells from apoptosis. Its correlation with chemoresistance of cancer cells has attracted much attention. But how Akt affects vincristine-induced cell death in retinoblastoma is unknown. Here we show that Akt activity is involved in vincristine-induced cytotoxicity in retinoblastoma SO-Rb50 cells. Inhibition of Akt can decrease the survival of both sensitive and vincristine-resistant SO-Rb50 cells and increase the sensitivity of both cell lines to vincristine by enhancing the cell apoptosis and increasing the cellular accumulation of the drug. Akt may be a target for reducing drug resistance that improves the treatment for retinoblastoma.
AuthorsHao Zhang, Bin Li, Shu-wei Bai, Hui-juan Wang
JournalCancer investigation (Cancer Invest) Vol. 28 Issue 2 Pg. 156-65 (Feb 2010) ISSN: 1532-4192 [Electronic] England
PMID19968493 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Vincristine
  • Proto-Oncogene Proteins c-akt
Topics
  • Cell Cycle
  • Cell Death
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm
  • Humans
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Retinal Neoplasms (metabolism)
  • Retinoblastoma (metabolism, pathology)
  • Vincristine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: